Acurx Pharmaceuticals's total assets for Q3 2025 were $6.11B, a decrease of 0.00% from the previous quarter. ACXP total liabilities were $2.47B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.